A cross-sectional study of knowledge and barriers in uptake of cervical cancer screening

More than 90% of instances of cervical cancer in women occur in developing nations, making it the second most frequent malignancy in women globally. About 15% of cancer-related fatalities worldwide are attributed to India, primarily in rural regions. This harmful condition can be effectively prevented by developing awareness campaigns and offering early Screening as a viable management option. From January 1, 2024, to June 30, 2024, a prospective questionnaire-based survey was carried out among women. Students made up the majority of the research population. There were 340 ladies among them. The majority of the 292 women (86%) who have not attended Screening gave a variety of excuses. Of the 48 women who showed up for the test, 23 (or 47.9%) had different symptoms and were receiving treatment. Three of these individuals were found to have cervical cancer. Obstacles were noted, including a weak economy, cultural legacies, ignorance, a shortage of women in the testing facilities, etc. Pap smear testing facilities must be available to all medical professionals and primary healthcare facilities.